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Interactions of protein kinase C (PKC) and CAMP-dependent protein kinase (PKA) systems were investigated in HL60 
cells. It was found that the differentiating effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) were potentiated by 
dibutyryl CAMP (dbcAMP) or prostaglandin E, (PGE,). In addition, dbcAMP or PGE, inhibited TPAinduced binding 
of PKC to plasma membrane, leading to decreased protein phosphorylation, and promoted subsequent redistribution 
of enzyme to the nuclear membrane region. The findings are consistent with the hypothesis that PKC and PKA systems 
regulate cooperatively the phenotypical differentiation of leukemic cells. 
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1. INTRODUCTION 
Human promyelocytic HL60 cells can be in- 
duced to differentiate either to monocytic macro- 
phage-like cells or to granulocytes. Differentiation 
to monocytes is induced by phorbol esters [ 11, 
while acquisition of granulocytic properties can be 
achieved by dimethyl sulfoxide [2], retinoic acid [3] 
or CAMP derivatives [4]. Recent evidence supports 
a two-step model for the induction of terminal dif- 
ferentiation. It appears that the arly events, which 
are associated with growth arrest and precommit- 
ment to differentiate, are not differentiation 
lineage-specific [5]. The choice of a specific dif- 
ferentiation lineage is regulated by late events. The 
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existence of non-differentiation lineage specific 
mechanisms would suggest a certain degree of in- 
teraction between the two sets of differentiation in- 
ducers. Indeed, dimethyl sulfoxide and retinoic 
acid were shown to potentiate the effect of TPA, 
the most effective phorbol ester, on monocytic dif- 
ferentiation of HL60 cells [6]. 
In the present work, we investigated the possible 
effect of CAMP elevating agents on TPA-induced 
cell differentiation. We found that CAMP poten- 
tiated the monocytic differentiation of HL60 cells. 
Perhaps related to this effect, immunocytochemi- 
cal studies also revealed a stimulatory effect of 
CAMP on the TPA-induced translocation of PKC 
to the nuclear membrane. 
2. MATERIALS AND METHODS 
2.1. Materials 
TPA, PGEz, dbcAMP and the diagnostic kits for the 
histochemical staining of specific and nonspecific esterases and 
acid phosphatase were purchased from Sigma; latex particles 
(diameter, 2.7 pm) were from Polyscience; the Vectastain 
biotin-avidin-peroxidase kit was from Vector Laboratories; 
fluorescein-conjugated goat anti-rabbit IgG was from Cooper 
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Biomedical; ampholites (pH ranges of 3.5-10 and 5-7) were 
from LKB Instruments; [‘*P]orthophosphate (carrier free, in 
water) was from ICN Radiochemicals. 
2.2. Cell culture 
Human promyelocytic leukemia cell line HL60 [7] was con- 
tinuously cultured in RPM1 1640 medium (Gibco) supple- 
mented with 20% heat-inactivated fetal calf serum, penicillin- 
streptomycin (50 units/ml and 50 pg/ml, respectively) and 
glutamine (2 mM). Cells (passage number: 26-41; doubling 
time: 27 h) were harvested for experiments at a density of 
0.5-0.6 x 106/ml. 
2.3. Immunocytochemical localization of PKC 
Polyclonal antisera against PKC were raised in rabbits as 
described [8] and kindly donated by Peggy R. Girard in our 
laboratory. The cells were diluted into plastic dishes (4.5 x 
lOs/ml) and were treated with TPA and/or dbcAMP as in- 
dicated in the legends to figs 1 and 2. The cells were pelleted on 
slides using cytospin (5 min), followed by fixation (30 min) with 
4% (w/v) paraformaldehyde and 0.1% glutaraldehyde in 
50 mM Tris-HCI (pH 7.5), and washing (7.5 min) with 0.2% 
(w/v) Triton X-100. The immunostaining procedures (fig.1) 
were essentially the same as originally described [9] and 
reported elsewhere [lo]. Briefly, cells were successively in- 
cubated with 1% horse serum and 1% goat serum in Tris- 
buffered saline for 20 min each. Incubations with 1: 500 dilu- 
tions of primary antisera were performed for 2 h at room 
temperature or overnight at 4°C. This step was followed by 
washing with Tris-buffered saline and incubating with 1% horse 
serum for 10 min. Finally, cells were incubated with diamino- 
benzidine (25 mg) and 8% hydrogen peroxide (10 ~1) in 50 ml 
of ice-cold Tris-buffered saline (fig.1). For immunofluorescence 
visualization of PKC (fig.2), the cells were fixed, pretreated 
with the antisera and fluorescein-conjugated goat anti-rabbit 
IgG [9]. Preimmune serum was used as control for both 
methods, which yielded little or no immunostainings 
(micrographs not shown). 
Table 1 
Effects of TPA and CAMP on differentiation of HL60 cells 
Treatment Cell at- Marker of differentiation 
tachment 
Non-speci- Acid phos- Phagocy- 
fit esterase phatase tosis 
None 2* I 3*1 1+1 o+ 0 
TPA lo& 3 14 + 4 7t2 17+ 5 
dbcAMP 2* 2 7*2 2*1 o+ 0 
TPA + 
dbcAMP 55 * 11 60 + 7 72 + 9 65 & 12 
For attachment studies, cells were cultured for 24 h in the 
absence or presence of 1 nM TPA and/or 0.6 mM dbcAMP, as 
indicated; dbcAMP was added 1 h prior to TPA. For the 
studies of differentiation marker enzymes and phagocytosis, 
cells were cultured as above for 7 days. The percentages of cells 
(mean + SE) showing the positive characteristics in 3 Petri 
dishes from each treatment were presented 
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2.4. Radiolabeling of cellular proteins and their separation by 
two-dimensional gel electrophoresis 
The cells (1 x 106/ml) were incubated in fresh RPM1 1640 
medium with ‘*Pi (0.5 mCi/ml) for 4 h, with 100 nM TPA or 
100 nM TPA plus 1 mM dbcAMP for varying durations as in- 
dicated in the legend to fig.3. Incorporations of 32P were ter- 
minated and proteins separated by the two-dimensional gel 
electrophoresis according to the procedure of O’Farrells [I 1] as 
described [ 121. Aliquots, corresponding to about 35 gg protein 
and containing 2.3 x lo5 cpm of acid-precipitable radioactivity, 
were loaded onto first-dimension (isoelectric focusing) gels. The 
second-dimension SDS gels contained 10% polyacrylamide. 
The 32P-labeled proteins were detected by autoradiography and 
the radioactivity of specific proteins was measured as described 
[131. 
2.5. Other methods 
Cells attached to the plastic dish were estimated after shaking 
the dish gently to distinguish them from non-attached cells. 
Histochemical stains were used to evaluate the macrophage 
phenotypic properties of differentiated HL60 cells; Sigma 
diagnostic kits were used according to the instructions for the 
identifications of specific and nonspecific esterases and acid 
Fig. 1. Effects of 1 nM TPA and dbcAMP, present singly or in 
combination, on immunocytochemical localization of PKC in 
HL60 cells. The cells were untreated (A), or treated with 
0.6 mM dbcAMP plus 1 nM TPA for 4 h (B), or with 1 nM 
TPA for 4 h (C) or 8 h (D). Visualization of PKC was 
performed with the immunoperoxidase method. Arrowheads 
indicate accumulation of immunoproducts. 
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phosphatase. The activity of phagocytosis was determined by 
the uptake of latex particles. Briefly, cells (5 x 10’) were washed 
and resuspended in 1 ml serum-free RPM1 1640 medium con- 
taining the particles (5 x lOs/ml) in a polypropylene tube. After 
I h incubation at 37”C, cells were washed twice and resuspend- 
ed in 0.5 ml medium. Cells ingesting more than 3 particles per 
cell were defined as phagocytosis positive and approx. 200 
viable cells were examined microscopically. 
3. RESULTS 
3.1. Potentiating effect of CAMP on TPA-induced 
cell differentiation 
A low concentration of TPA (1 nM) and 
dbcAMP (0.6 mM) had little or no effect on dif- 
ferentiation of HL60 cells when present individual- 
ly. dbcAMP, however, acted synergistically to 
greatly increase the differentiating activity of TPA 
(table 1). It should be stressed here that the concen- 
tration of dbcAMP had to be diluted from 0.6 mM 
to at least 0.2 mM after an initial 4 h of incubation 
in order for its potentiating effect to be observed. 
0.6 mM butyric acid, also diluted 3-fold after 4 h, 
was without effect (data not shown). A high con- 
centration (100-200 nM) of PGE2 similarly poten- 
tiated the differentiating effect of 1 nM TPA as 
dbcAMP did, provided the cells were washed free 
of this agent after 4 h of incubation (data not 
shown). Incubation of cells for 4 h with 200 nM 
PGE2 increased cellular CAMP from 2.4 k 0.2 to 
23.1 f 1.7 pmol/106 cells (triplicate determina- 
tions; P < 0.001). It appeared that a high concen- 
tration of CAMP stimulated initiation of cell 
differentiation, but inhibited the actual process of 
cell maturation. 
A high (100 nM) concentration of TPA about 
Fig.2. Effects of 100 nM TPA and dbcAMP, present singly or in combination, on immunocytochemical localization of PKC in HL60 
cells. The cells were untreated (A), or treated with 100 nM TPA for 30 min (B) or 2 h (C); or with 0.6 mM dbcAMP in the absence 
of TPA for 2 h (D); or with 0.6 mM dbcAMP plus 100 nM TPA for 30 min (E) or 2 h (F). Visualization of PKC was performed using 
the immunofluorescence method. Arrowheads indicate accumulation of immunoproducts. 
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40-50 min treatment was sufficient to induce at- 
tachment of 70-80% of cells (which was obser- 
vable 48 h later). In the co-presence of dbcAMP 
and 100 nM TPA, however, a similar rate of cell 
attachment required only 20-30 min treatment 
(data not shown). 
3.2. Effect of CAMP on TPA-induced PKC 
redistribution 
In a previous paper [14] we showed that in at- 
tached cells PKC molecules were associated predo- 
minantly with the nucleus. Since nuclear PKC 
could have a specific role in the regulation of dif- 
ferentiation, it was of interest to examine a pos- 
sible CAMP effect on the TPA-induced redistribu- 
tion of PKC. In the following experiments im- 
munocytochemical methods were used to visualize 
intracellular localization of PKC. A highly specific 
antibody, frequently used in other studies 
[9,10,14-191, was employed. When cells were 
treated with 1 nM TPA plus dbcAMP (0.6 mM) 
for 4 h (fig. lB), PKC molecules were concentrated 
around the nuclear membrane. Direct measure- 
ment of enzyme activity revealed that only about 
lo-20% of total PKC activity was associated with 
isolated nuclei (data not shown) indicating that 
either (i) the association of enzyme with nuclear 
membrane was weak, or (ii) at this early stage most 
PKC molecules were associated with other struc- 
tural (for example cytoskeletal) elements near the 
nucleus. However, as we have shown earlier [14], 
a major fraction of PKC molecules becomes tight- 
ly associated with the nucleus at later stages of dif- 
ferentiation. In the presence of 1 nM TPA alone, 
a similar accumulation of PKC around the nuclear 
membrane required 8 h treatment (fig.lD); after 
4 h treatment (fig. 1C) with TPA alone the enzyme 
was present mainly in the plasma membrane and 
cytoplasmic compartments. 
Treatment of cells with high concentration of 
TPA (100 nM) induced translocation of PKC from 
the cytoplasm to the plasma membrane in 30 min 
(fig.2, compare A and B), while after 2 h treatment 
the enzyme was redistributed to the cytoplasm 
(fig.2C). Addition of dbcAMP to cells alone did 
not change PKC distribution (fig.2D); however, (i) 
after 30 min treatment it seemed to inhibit TPA- 
induced PKC binding to plasma membrane (fig. 
2E), and (ii) after 2 h treatment it clearly promoted 
TPA-dependent redistribution of enzyme to the 
nuclear membrane region (fig.2F). These data were 
consistent with those obtained with low TPA con- 
centration (fig. l), except that at high TPA concen- 
tration the effects of dbcAMP on PKC distribu- 
tion were faster. PGEz mimicked the *effect of 
dbcAMP on PKC distribution (data not shown). 
Fig.3. Effect of dbcAMP on the TPA-stimulated protein phosphorylation in HL60 cells. The cells were incubated with “P, for 4 h 
and were untreated (a), or treated with 100 nM TPA for the final 5 (b), 30 (c) and 120 min (d); or with 100 nM TPA plus 0.6 mM 
dbcAMP for the final 5 (f), 30 (g) and 120 min (h) of the 4-h incubation period. dbcAMP was added 30 min prior to TPA in all cases. 
Cells were also treated with 0.6 mM dbcAMP alone for 150 min (e) or 5, 30 and 120 min (not shown). About 10’ cpm of the acid- 
precipitable radioactivity (35 pg protein) was loaded onto each gel; autoradiographs were exposed for 3 days. The radioactivity of the 
reference protein (R) remained constant in each experiment. 
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3.3. Effect of CAMP on TPA-induced protein 
phosphorylation and dephosphorylation 
In order to verify whether altered PKC distribu- 
tion was accompanied by changes in protein 
phosphorylation pattern, cells were labelled with 
32Pi and treated with TPA (100 nM) and/or 
dbcAMP (1 mM) for 5-120 min. Protein Ia (MI 
66000, pZ 5.6), previously referred to as protein 3 
[20], is located in the plasma membrane [20] and is 
a particularly good substrate for PKC; its phos- 
phorylation was maximally stimulated by TPA in 
5-30 min (fig.3, comparing a-c), when a signifi- 
cant portion of PKC was translocated to the 
plasma membrane (fig.2B). After 2 h of the TPA 
treatment, phosphorylation of protein Ia was 
greatly reduced (by 70% as determined by measur- 
ing its actual radioactivity) (fig.3d), possibly 
reflecting a disappearance of the membrane- 
associated PKC (fig.2C). In the co-presence of 
TPA and 1 mM dbcAMP peak phosphorylation of 
protein Ia was observed after 5 min (fig.3f); 
however, this protein lost 65% of its 32P activity 
after 30 min (fig.3g). dbcAMP had a similar effect 
when the concentration of TPA was 1 nM, except 
that dephosphorylation of protein Ia took place at 
a much later time (figures not shown). It is still 
worth noting that dbcAMP also inhibited, 
although less markedly, the TPA-stimulated 32P 
labelling of proteins Ib (Mr 63000; pZ 5.45-5.65) 
and lb (Mr 80000; pZ 5.0) (fig.3g,h). 
4. DISCUSSION 
Most receptor-mediated mechanisms utilize 
either the PKA or PKC messenger systems 
[21-241. TPA has been known for some time to af- 
fect CAMP production in many cells [25-331; 
however, only a few reports have dealt with effects 
of CAMP on the PKC system. A few years ago one 
of us reported multiple effects of CAMP on the 
TPA-mediated protein phosphorylation in S49 
mouse lymphoma cells [34]. Since then, CAMP has 
been shown to modify TPA-induced protein 
phosphorylation in other cells too [35,36], and to 
promote PKC transfer to the nuclear compartment 
in lymphocytes [37]. The kinetics of phosphoryla- 
tion-dephosphorylation of plasma membrane pro- 
tein Ia, shown in the present paper, were consistent 
with a mechanism where CAMP promoted PKC 
dissociation from, rather than inhibited its initial 
association with, the plasma membrane. The 
absence of PKC from the plasma membrane would 
presumably increase the rate of dephosphorylation 
of its substrates. However, it was shown [38] that 
CAMP stimulated dephosphorylation of several 
proteins in S49 mouse lymphoma cells by a 
mechanism which was apparently unrelated to the 
activity state of PKC. This raises the possibility 
that in the present case as well the CAMP effect on 
protein dephosphorylation was unrelated to its ef- 
fect on PKC distribution. More experiments will 
be needed to clarify this point. 
The mechanism by which CAMP can modify 
PKC distribution is presently unknown. However, 
association of PKC with the nucleus, which 
becomes tight only at later stages of differentiation 
[14], is apparently an important mechanism by 
which certain steps of differentiation, along with 
the appearance of various differentiation markers, 
are regulated. Therefore, it is a significant observa- 
tion that CAMP, which promoted the TPA- 
dependent accumulation of PKC around the 
nuclear membrane, also potentiated the TPA ef- 
fect on cell differentiation. 
In summary, these experiments show that 
CAMP, similarly to dimethyl sulfoxide and retinoic 
acid [6], also potentiates the effect of TPA on cell 
differentiation. We are presently investigating the 
possibility that these agents have similar effects on 
PKC distribution as well. 
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